Elite Pharma Inc (ELTP)
Fair Value23.0% Upside
Undervalued
Market Cap317.8 M
P/E5.6x
Yield0.0%
HealthGreat
OTC Markets
Featured in
Rapid Revenue Growth
Profitability Leaders
Encision Inc (ECIA)
Fair Value44.6% Upside
Undervalued
Market Cap685.313 K
P/E-1.8x
Yield0.0%
HealthFair
OTC Markets
Essilor International SA (ESLOY)
Fair Value13.6% Upside
Fair
Analyst50.8% Upside
Market Cap87.592 B
P/E30.1x
Yield2.0%
HealthGood
OTC Markets
Extendicare Inc (EXETF)
Fair Value-19.6% Downside
Overvalued
Market Cap2.096 B
P/E23.8x
Yield1.7%
HealthGreat
OTC Markets
Featured in
Overvalued Stocks
First Choice Healthc (FCHS)
Fair Value-33.7% Downside
Overvalued
Market Cap273.553 K
P/E0.0x
Yield0.0%
HealthWeak
OTC Markets
Featured in
Overvalued Stocks
Fresenius SE & Co KGaA ADR (FSNUY)
Fair Value19.8% Upside
Undervalued
Analyst18.1% Upside
Market Cap30.651 B
P/E16.8x
Yield1.5%
HealthGood
OTC Markets
Featured in
Bullish Trend Stocks
Getinge Industrier AB (GNGBY)
Fair Value13.7% Upside
Fair
Market Cap7.025 B
P/E24.9x
Yield1.4%
HealthGood
OTC Markets
Featured in
Bullish Trend Stocks
Near 52-Week Highs
Global Asset Management Group Inc (GAMG)
Fair Value-46.6% Downside
Overvalued
Market Cap175.9 M
P/E-311.7x
Yield0.0%
HealthWeak
OTC Markets
Featured in
Overvalued Stocks
Global Innovative Platforms Inc (GIPL)
Fair Value-50.7% Downside
Expensive
Market Cap24.876 M
P/E-36.7x
Yield0.0%
HealthFair
OTC Markets
Featured in
Overvalued Stocks
Grown Rogue International Inc (GRUSF)
Fair Value-41.5% Downside
Overvalued
Market Cap119.8 M
P/E-25.1x
Yield0.0%
HealthGood
OTC Markets
Featured in
Overvalued Stocks
GSK plc (GLAXF)
Fair Value55.2% Upside
Bargain
Market Cap104.9 B
P/E15.9x
Yield3.6%
HealthGreat
OTC Markets
Featured in
Profitability Leaders
Upcoming Ex-Dividend
Guided Therapeutics Inc (GTHP)
Fair Value15.0% Upside
Fair
Market Cap26.065 M
P/E-7.2x
Yield0.0%
HealthFair
OTC Markets
Harvard Apparatus Regenerative Technology Inc (HRGN)
Fair Value-6.8% Downside
Fair
Market Cap26.705 M
P/E-4.0x
Yield0.0%
HealthFair
OTC Markets
Hepion Pharmaceuticals Inc (HEPA)
Fair Value-11.7% Downside
Fair
Market Cap6.766 M
P/E-2.1x
Yield0.0%
HealthGood
OTC Markets
Inhibitor Therapeutics Inc (INTI)
Fair Value-54.2% Downside
Expensive
Market Cap15.467 M
P/E-4.7x
Yield0.0%
HealthFair
OTC Markets
Featured in
Overvalued Stocks
Innate Pharma SA (IPHYF)
Fair Value11.3% Upside
Fair
Market Cap209.3 M
P/E-3.6x
Yield0.0%
HealthFair
OTC Markets
International Stem Cell Corp (ISCO)
Fair Value-10.6% Downside
Fair
Market Cap3.986 M
P/E-6.8x
Yield0.0%
HealthGood
OTC Markets
Kuros Biosciences AG (CSBTF)
Fair Value4.9% Upside
Fair
Market Cap1.066 B
P/E119.7x
Yield0.0%
HealthGreat
OTC Markets
Featured in
Rapid Revenue Growth
Lakefront Biotherapeutics NV (GLPGF)
Fair Value3.6% Upside
Fair
Market Cap1.891 B
P/E2.7x
Yield0.0%
HealthGreat
OTC Markets
LogicMark Inc (LGMK)
Fair Value-11.4% Downside
Fair
Analyst125.0% Upside
Market Cap899.759 K
P/E-0.1x
Yield0.0%
HealthFair
OTC Markets
Marimed Inc (MRMD)
Fair Value29.0% Upside
Undervalued
Analyst191.4% Upside
Market Cap34.581 M
P/E-2.3x
Yield0.0%
HealthGood
OTC Markets
Medical Care Technologies Inc (MDCE)
Fair Value-33.3% Downside
Fair
Market Cap583.943 K
P/E2.9x
Yield0.0%
HealthGreat
OTC Markets
Featured in
Overvalued Stocks
Medical Facilities Corp (MFCSF)
Fair Value17.7% Upside
Fair
Market Cap184.2 M
P/E10.6x
Yield2.3%
HealthGreat
OTC Markets
Featured in
High-Quality Earnings Stocks